Airway epithelial cell-specific delivery of lipid nanoparticles loading siRNA for asthma treatment

被引:17
|
作者
Zhang, Mengjun [1 ]
Jiang, Huiyang [1 ]
Wu, Lan [1 ]
Lu, Haoyu [1 ]
Bera, Hriday [1 ,2 ]
Zhao, Xing [1 ]
Guo, Xiong [1 ]
Liu, Xulu [1 ]
Cun, Dongmei [1 ]
Yang, Mingshi [1 ,3 ]
机构
[1] Shenyang Pharmaceut Univ, Wuya Coll Innovat, Wenhua Rd, 103, Shenyang 110016, Peoples R China
[2] Dr BC Roy Coll Pharm & Allied Hlth Sci, Durgapur 713212, West Bengal, India
[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen, Denmark
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Pulmonary delivery; siRNA; Lipid nanoparticles; Asthma; Airway epithelial cells; THYMIC STROMAL LYMPHOPOIETIN; IN-VIVO; ICAM-1; EXPRESSION; GENE DELIVERY; PULMONARY; INFLAMMATION; MACROPHAGES; RECEPTOR; MUCUS; RESPONSES;
D O I
10.1016/j.jconrel.2022.10.020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
With specific and inherent mRNA cleaving activity, small interfering RNA (siRNA) has been deemed promising therapeutics to reduce the exacerbation rate of asthma by inhibiting the expression and release of proin-flammatory cytokines from airway epithelial cells (AECs). To exert the therapeutic effects of siRNA drugs, nano -formulations with high efficiency and safety are required to deliver these nucleic acids to the target cells. Herein, we exploited novel inhaled lipid nanoparticles (LNPs) targeting intercellular adhesion molecule-1 (ICAM-1) receptors on the apical side of AECs. This delivery system is meant to enhance the specific delivery efficiency of siRNA in AECs to prevent the expression of proinflammatory cytokines in AECs and the concomitant symptoms in parallel. A cyclic peptide that resembles part of the capsid protein of rhinovirus and binds to ICAM-1 receptors was initially conjugated with cholesterol and subsequently assembled with ionizable cationic lipids to form the LNPs (Pep-LNPs) loaded with siRNA against thymic stromal lymphopoietin (TSLP siRNA). The obtained Pep-LNPs were subjected to thorough characterization and evaluations in vitro and in vivo. Pep-LNPs significantly enhanced cellular uptake and gene silencing efficiency in human epithelial cells expressing ICAM-1 in vitro, exhibited AEC-specific delivery and improved the gene silencing effect in ovalbumin-challenged asthmatic mice after pulmonary administration. More importantly, Pep-LNPs remarkably downregulated the expression of TSLP in AECs, effectively alleviated inflammatory cell infiltration, and reduced the secretion of other proinflammatory cytokines, including IL-4 and IL-13, as well as mucus production in asthmatic mice. This study demonstrates that Pep-LNPs are safe and efficient to deliver siRNA drugs to asthmatic AECs and could potentially alleviate allergic asthma by inhibiting the overexpression of proinflammatory cytokines in the airway.
引用
收藏
页码:422 / 437
页数:16
相关论文
共 50 条
  • [31] Screening of siRNA nanoparticles for delivery to airway epithelial cells using high-content ana-lysis
    Hibbitts, Alan
    Lieggi, Nora
    McCabe, Olive
    Thomas, Warren
    Barlow, James
    O'Brien, Fiona
    Cryan, Sally-Ann
    THERAPEUTIC DELIVERY, 2011, 2 (08) : 987 - 999
  • [32] Airway epithelial-targeted nanoparticles for asthma therapy
    Kan, Stanislav
    Hariyadi, Dewi Melani
    Grainge, Christopher
    Knight, Darryl A.
    Bartlett, Nathan W.
    Liang, Mingtao
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2020, 318 (03) : L500 - L509
  • [33] The application of M12L24 nanocages as cell-specific siRNA delivery agents in vitro
    Bobylev, Eduard O.
    Zeng, Ye
    Weijgertse, Kevin
    Koelman, Emma
    Meijer, Eline M.
    de Bruin, Bas
    Kros, Alexander
    Reek, Joost N. H.
    CHEM, 2023, 9 (06): : 1578 - 1593
  • [34] Cell-Specific DNA Methylation Signatures in Asthma
    Thibeault, Andree-Anne Hudon
    Laprise, Catherine
    GENES, 2019, 10 (11)
  • [35] ORFeome-based search of airway epithelial cell-specific novel human β-defensin genes
    Kao, CY
    Chen, Y
    Zhao, YH
    Wu, R
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2003, 29 (01) : 71 - 80
  • [36] Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia
    Guo, Jianfeng
    Cahill, Mary R.
    McKenna, Sharon L.
    O'Driscoll, Caitriona M.
    BIOTECHNOLOGY ADVANCES, 2014, 32 (08) : 1396 - 1409
  • [37] Recent Advancement in Exosome-Inspired Lipid Nanovesicles for Cell-Specific Drug Delivery
    Sunkara, Siva Prasad
    Kar, Nihar Ranjan
    Kareemulla, Shaik
    Sarma, Koushik Narayan
    Thool, Komal Umare
    Katual, Manoj Kumar
    Kondrapu, Pydiraju
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2024, 14 (04) : 1085 - 1095
  • [38] Oral delivery of siRNA lipid nanoparticles: Fate in the GI tract
    Rebecca L. Ball
    Palak Bajaj
    Kathryn A. Whitehead
    Scientific Reports, 8
  • [39] Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
    Gaurav Sahay
    William Querbes
    Christopher Alabi
    Ahmed Eltoukhy
    Sovan Sarkar
    Christopher Zurenko
    Emmanouil Karagiannis
    Kevin Love
    Delai Chen
    Roberto Zoncu
    Yosef Buganim
    Avi Schroeder
    Robert Langer
    Daniel G Anderson
    Nature Biotechnology, 2013, 31 : 653 - 658
  • [40] Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity
    Kathryn A. Whitehead
    J. Robert Dorkin
    Arturo J. Vegas
    Philip H. Chang
    Omid Veiseh
    Jonathan Matthews
    Owen S. Fenton
    Yunlong Zhang
    Karsten T. Olejnik
    Volkan Yesilyurt
    Delai Chen
    Scott Barros
    Boris Klebanov
    Tatiana Novobrantseva
    Robert Langer
    Daniel G. Anderson
    Nature Communications, 5